cefodizime has been researched along with dibekacin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Suzuki, Y; Yokota, N | 1 |
Deguchi, K; Furukawa, T; Hyodo, A; Miyake, Y; Uji, T | 1 |
3 other study(ies) available for cefodizime and dibekacin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. IV. Synergistic action with dibekacin].
Topics: Bacteria; Cefotaxime; Dibekacin; Drug Resistance, Microbial; Drug Synergism | 1992 |
[Therapeutic efficacy of cefodizime in combination with aminoglycosides against systemic infections caused by Pseudomonas aeruginosa in immunocompromised tumour bearing mice].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Immunocompromised Host; Male; Mice; Mice, Inbred Strains; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Sisomicin | 1993 |